Skip to main content

Table 2 Biomarkers’ conversion rate between paired PT and LNM

From: Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer

Marker

N

Positive in PT

Positive in LNM

Conversion rate PT → LNM

  

N (%)

N (%)

(−) → (+) N (%)

(+) → (−) N (%)

N (%)

kappa coefficient (95% CI)

mRNA TWIST1

29

14 (48)

17 (59)

9 (31)

6 (21)

15 (52)

−0.03 (−0.38-0.33)

mRNA SNAIL

29

16 (55)

14 (48)

3 (10)

5 (17)

8 (28)

0.45 (0.13-0.77)

mRNA SLUG

29

14 (48)

15 (52)

6 (21)

7 (24)

13 (45)

0.1 (−0.26-0.47)

TWIST1

39

15 (38)

17 (44)

10 (26)

8 (20)

18 (46)

0.05 (−0.26-0.36)

SNAIL

38

15 (39)

29 (76)

17 (45)

3 (8)

20 (53)

0.05 (−0.18-0.29)

SLUG

39

10 (26)

7 (18)

7 (18)

4 (10)

11 (28)

0.18 (−0.16-0.52)

Vimentin

42

5 (12)

4 (10)

1 (2)

2 (5)

3 (7)

0.63 (0.24-1)

E-cadherin

40

35 (87)

35 (87)

0 (0)

0 (0)

0 (0)

1 (1.0-1.0)

ER

40

23 (57)

28 (70)

6 (15)

1 (3)

7 (18)

0.63 (0.39-0.87)

PgR

41

26 (63)

32 (78)

9 (22)

3 (7)

12 (29)

0.31 (0.02-0.6)

HER2

34

5 (15)

6 (18)

1 (3)

0 (0)

1 (3)

0.89 (0.68-1)

  1. Conversion described as the number (percentage) of discordant cases and kappa coefficient of concordance.